Ivabradine Hydrochloride CAS 148849-67-6 Purity >99.5% (HPLC) API Factory

Chemical Name: Ivabradine Hydrochloride Synonyms: Ivabradine HCl CAS: 148849-67-6 Purity: >99.5% (HPLC)  Appearance: White to Off-White Crystalline Powder  E-Mail: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureRuifu Chemical Supply Ivabradine Hydrochloride Intermediates With High Purity Ivabradine Hydrochloride CAS 148849-67-6 4,5-Dimethoxy-1-Cyanobenzocyclobutane CAS 35202-54-1 (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane Hydrochloride CAS 866783-13-3 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one CAS 73942-87-7 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one CAS 148870-57-9 3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-one CAS 85175-59-3
Item Specifications
Appearance White to Off-White Crystalline Powder
Identification HPLC/UV Complies
Purity / Analysis Method >99.5%
Loss on Drying <1.00% (Dry it at 105℃ in an electric air blowing dryer till a constant weight)
Moisture Content <1.00%
Residue on Ignition <0.20%
Max Single Impurity <0.50%
Total Impurities <0.50%
Optical Isomer <0.50%
Assay >99.5%
Heavy Metals <20ppm
Specific Rotation +6.5° ~ +8.5° (on dried basis, 1% solution in DMSO)
Test Standard Enterprise Standard
Usage API 

Description:

Specifications:

Package & Storage:

Chemical Name Ivabradine Hydrochloride
Synonyms Ivabradine HCl
CAS Number 148849-67-6
CAT Number RF-PI1812
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C27H36N2O5·HCl
Molecular Weight 505.05  
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

Ivabradine Hydrochloride (CAS: 148849-67-6), In an effort to develop angina agents without the unwanted negative inotropic and hypotensive effects associated with b-adrenergic blockers and calcium channel blockers, a new class of heart-rate reducing compounds that act specifically on the sinoatrial (SA) node has been explored. These bradycardic agents interact directly with the pacemaking cell of the SA node and the hyperpolarization- activated If the primary pacemaking current. Ivabradine has evolved as a specific inhibitor of If current through its contact with f-channels on the intracellular side of the plasma membrane. As a consequence, Ivabradine reduces the speed of diastolic depolarization and decreases heart rate. It has been approved for the treatment of chronic stable angina and provides a viable alternative to patients with a contraindication or intolerance of b-blockers. Evaluation is also underway for the potential treatment of ischemic heart disease. 

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours